Cargando…
Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis
Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by multiple factors that ultimately lead to structural changes in normal lung tissue. Currently, pulmonary fibrosis is a global disease with a high degree of heterogeneity and mortality rate. Nitidine and pirfenido...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470008/ https://www.ncbi.nlm.nih.gov/pubmed/37664726 http://dx.doi.org/10.1016/j.heliyon.2023.e19308 |
_version_ | 1785099576121753600 |
---|---|
author | Wang, Meng-Chuan |
author_facet | Wang, Meng-Chuan |
author_sort | Wang, Meng-Chuan |
collection | PubMed |
description | Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by multiple factors that ultimately lead to structural changes in normal lung tissue. Currently, pulmonary fibrosis is a global disease with a high degree of heterogeneity and mortality rate. Nitidine and pirfenidone have been approved for treating pulmonary fibrosis, and the quest for effective therapeutic drugs remains unabated. In recent years, the anti-pulmonary fibrosis properties of natural flavonoids have garnered heightened attention, although further research is needed. In this paper, the resources, structural characteristics, anti-pulmonary fibrosis properties and mechanisms of natural flavonoids were reviewed. We hope to provide potential opportunities for the application of flavonoids in the fight against pulmonary fibrosis. |
format | Online Article Text |
id | pubmed-10470008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104700082023-09-01 Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis Wang, Meng-Chuan Heliyon Review Article Pulmonary fibrosis is an enduring and advancing pulmonary interstitial disease caused by multiple factors that ultimately lead to structural changes in normal lung tissue. Currently, pulmonary fibrosis is a global disease with a high degree of heterogeneity and mortality rate. Nitidine and pirfenidone have been approved for treating pulmonary fibrosis, and the quest for effective therapeutic drugs remains unabated. In recent years, the anti-pulmonary fibrosis properties of natural flavonoids have garnered heightened attention, although further research is needed. In this paper, the resources, structural characteristics, anti-pulmonary fibrosis properties and mechanisms of natural flavonoids were reviewed. We hope to provide potential opportunities for the application of flavonoids in the fight against pulmonary fibrosis. Elsevier 2023-08-20 /pmc/articles/PMC10470008/ /pubmed/37664726 http://dx.doi.org/10.1016/j.heliyon.2023.e19308 Text en © 2023 The Author https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Wang, Meng-Chuan Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title | Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title_full | Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title_fullStr | Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title_full_unstemmed | Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title_short | Natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
title_sort | natural plant resource flavonoids as potential therapeutic drugs for pulmonary fibrosis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470008/ https://www.ncbi.nlm.nih.gov/pubmed/37664726 http://dx.doi.org/10.1016/j.heliyon.2023.e19308 |
work_keys_str_mv | AT wangmengchuan naturalplantresourceflavonoidsaspotentialtherapeuticdrugsforpulmonaryfibrosis |